Although laboratory studies suggest a role for TGF-β1 and VEGF in mediating carcinogenic effects of CNIs, no epidemiologic study has assessed TGF-β1 and VEGF in relation to cancer in solid organ transplant recipients. The gene discussed is VEGFA; the disease is cancer.